Key points are not available for this paper at this time.
High Resolution Image Download MS PowerPoint Slide The synthesis of active pharmaceutical ingredients (APIs) demands extensive resources, with solvents playing a pivotal role in shaping the safety, health, waste, and environmental impacts of chemical processes. To address the absence of a tailored metric for the requirements of the pharmaceutical industry to rapidly quantify and compare these impacts, we developed a novel tool providing concrete operational guidance to enhance sustainability, cost-effectiveness, and operational efficiency. This metric leverages a comprehensive data set, prioritizes critical impact categories, and evaluates solvent quantities relative to the product output. These features enable it to effectively identify areas of improvement in chemical processes and guide sustainable development initiatives. The experience of the application of the metric by a contract development and manufacturing organization to its processes is presented, demonstrating the effectiveness of the metric for internal benchmarking and establishing sustainability criteria. Furthermore, the metric provided structured, actionable guidelines to support daily process development activities, ultimately serving as a practical tool to achieve corporate environmental, social, and governance (ESG) objectives. While the described benchmarking is not proposed as a general industry standard, the method is adaptable to the unique context and requirements of any chemical or pharmaceutical company. Case studies underscore its capability to pinpoint high-impact solvents, support targeted interventions, and achieve notable reductions in sustainability impacts. Aligned with the United Nations Sustainable Development Goal for responsible production, this metric integrates seamlessly into process evaluation tools, enabling consistent, data-driven improvements. Designed to complement existing methodologies rather than replace them, it enhances chemical process assessments with a rapid, decision-focused approach tailored to the priorities and key impact categories of the pharmaceutical industry. This practical tool fosters sustainability and operational efficiency, addressing critical industry needs.
Ferrara et al. (Mon,) studied this question.